Physicochemical characteristics of soluble oligomeric A β and their pathologic role in Alzheimer's disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Soluble Aβ has been demonstrated to perturb metabolic processes, induce the release of deleterious reactive compounds, reduce blood flow, inhibit angiogenesis and induce mitochondrial apoptotic activity (Watson et al, 2005).”
From PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease‐protective variant PLCγ2 R522 (2021) · cites this paper as Watson et al, 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Self-citationNeuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Research works printed but not linked: 104
- 10.1074/jbc.271.34.20631 · DOI · Paper page
- 10.1074/jbc.272.35.22364 · DOI · Paper page
- 10.1074/jbc.272.34.21037 · DOI · Paper page
- 10.1093/protein/11.9.761 · DOI · Paper page
- 10.1006/bbrc.1997.7727 · DOI · Paper page
- 10.1074/jbc.M102223200 · DOI · Paper page
- 10.1083/jcb.107.6.2703 · DOI · Paper page
- 10.1126/science.1072994 · DOI · Paper page
- 10.1146/annurev.ne.17.030194.002421 · DOI · Paper page
- 10.1016/S0896-6273(01)00475-5 · DOI · Paper page
- 10.1046/j.1471-4159.1997.69051904.x · DOI · Paper page
- 10.1046/j.1471-4159.1999.0731393.x · DOI · Paper page
- 10.1385/JMN:22:1-2:5 · DOI
- 10.1016/S0304-3940(03)00898-X · DOI · Paper page
- 10.1073/pnas.0230450100 · DOI · Paper page
- 10.1006/bbrc.1994.2872 · DOI · Paper page
- 10.1046/j.1471-4159.1998.70020721.x · DOI · Paper page
- Kubo T, 2003, J Exp Neuropath Exp Neurol, 62, 248, 10.1093/jnen/62.3.248 · DOI
- 10.3109/13506129908993282 · DOI · Paper page
- 10.1021/tx025666g · DOI
- 10.1016/S0014-5793(97)01484-1 · DOI · Paper page
- 10.1523/JNEUROSCI.5543-03.2004 · DOI · Paper page
- Funato H, 1998, Am] Pathol, 152, 1633
- 10.1042/bst0300552 · DOI · Paper page
- 10.1111/j.1749-6632.2002.tb04812.x · DOI · Paper page
- 10.1161/01.ATV.0000095973.42032.44 · DOI · Paper page
- Roher AE, 2003, Mol Med, 9, 112, 10.1007/BF03402043 · DOI · Paper page
- 10.1073/pnas.90.22.10836 · DOI · Paper page
- 10.1111/j.1750-3639.1995.tb00578.x · DOI · Paper page
- 10.1007/s004010051116 · DOI
- Mohr M, 1999, Clin Exp Pathol, 47, 161
- 10.1017/S0317167100002651 · DOI
- 10.1212/WNL.38.8.1249 · DOI
- 10.1212/WNL.51.1.271 · DOI
- 10.1212/WNL.49.1.126 · DOI
- 10.1046/j.1440-1789.2000.00283.x · DOI
- Liberski PP, 2000, Folia Neuropathol, 38, 167
- Armstrong RA, 2003, Clin Neuropathol, 22, 209
- 10.1042/bst0300557 · DOI
- 10.1046/j.1471-4159.2003.02134.x · DOI
- 10.1016/S0002-9440(10)63993-4 · DOI · Paper page
- Holton JL, 2002, J Neuropathol Exp Neurol, 61, 254, 10.1093/jnen/61.3.254 · DOI · Paper page
- 10.1111/j.1749-6632.2000.tb06356.x · DOI · Paper page
- 10.1016/S0002-9440(10)65616-7 · DOI · Paper page
- 10.1111/j.1750-3639.1992.tb00704.x · DOI · Paper page
- Yamada S, 1991, Am] Physiol, 261, H1197
- 10.1111/j.1750-3639.1992.tb00703.x · DOI · Paper page
- 10.1016/S0002-9440(10)64644-5 · DOI · Paper page
- 10.1006/bbrc.1994.1634 · DOI
- 10.1006/bbrc.1995.1912 · DOI
- 10.1006/bbrc.1994.2740 · DOI
- 10.1074/jbc.270.16.9564 · DOI · Paper page
- 10.1021/bi972029u · DOI · Paper page
- 10.1038/nm0196-93 · DOI · Paper page
- 10.1038/nm0798-832 · DOI · Paper page
- 10.1021/bi001048s · DOI · Paper page
- 10.1038/nsb1195-990 · DOI · Paper page
- 10.1016/S0925-4439(00)00030-2 · DOI
- 10.1002/jnr.10859 · DOI · Paper page
- 10.1016/S0022-2836(02)01279-2 · DOI
- 10.1006/jmbi.2000.3559 · DOI · Paper page
- 10.1073/pnas.1237107100 · DOI · Paper page
- 10.1073/pnas.90.22.10573 · DOI · Paper page
- 10.1096/fj.01-0377com · DOI · Paper page
- 10.1016/S0006-3495(94)80717-9 · DOI · Paper page
- 10.1016/S0196-9781(02)00067-0 · DOI · Paper page
- 10.1111/j.1749-6632.1993.tb23046.x · DOI · Paper page
- Bhatia R, 2000, FASEB 1, 14, 1233, 10.1096/fasebj.14.9.1233 · DOI · Paper page
- 10.1016/S0361-9230(00)00370-1 · DOI · Paper page
- 10.1023/A:1010995121153 · DOI
- 10.1385/CBB:36:2-3:191 · DOI
- 10.1038/418291a · DOI · Paper page
- 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- Giulian D, 1996, I Neurosci, 16, 6021, 10.1523/JNEUROSCI.16-19-06021.1996 · DOI · Paper page
- 10.1074/jbc.273.45.29719 · DOI · Paper page
- 10.1016/S0006-8993(97)01318-8 · DOI · Paper page
- 10.1016/S0304-3940(02)00095-2 · DOI
- 10.1006/nbdi.2002.0481 · DOI · Paper page
- 10.1073/pnas.261562998 · DOI · Paper page
- Westerman MA, 2002, J Neurosci, 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 · DOI · Paper page
- 10.1111/j.1749-6632.1997.tb48459.x · DOI
- 10.1006/exnr.1997.6743 · DOI
- 10.1179/016164101101198758 · DOI · Paper page
- 10.1016/S0197-4580(00)82162-4 · doi:10.1016/s0197-4580(00)82162-4
- 10.1111/j.1749-6632.2000.tb06355.x · DOI
- 10.1006/exnr.1999.7055 · DOI
- 10.1016/S0021-9150(01)00660-8 · DOI
- 10.1073/pnas.97.17.9735 · DOI · Paper page
- 10.1152/ajpheart.00022.2002 · DOI · Paper page
- ladecola C. Cerebrovascular effects of amyloid-β peptides: mechanisms and implications for Alzheimer's dementia, 2003, Cell Mol Neurobiol, 23, 681
- 10.1074/jbc.274.4.2145 · DOI · Paper page
- 10.1074/jbc.M309938200 · DOI · Paper page
- 10.1111/j.1600-0854.2004.00159.x · DOI · Paper page
- 10.1093/embo-reports/kvd093 · DOI · Paper page
- 10.1002/psc.573 · DOI · Paper page
- 10.1086/375116 · DOI
- Plant LD, 2003, ] Neurosci, 23, 5531, 10.1523/JNEUROSCI.23-13-05531.2003 · DOI · Paper page
- 10.1523/JNEUROSCI.0974-04.2004 · DOI · Paper page
- Hartley DM, 1999, J Neurosci, 19, 8876, 10.1523/JNEUROSCI.19-20-08876.1999 · DOI · Paper page
- 10.1038/35050116 · DOI · Paper page
- 10.1016/S0031-9384(01)00524-8 · DOI · Paper page
- 10.1038/83292 · doi:10.1038/83292
- 10.1111/j.1750-3639.2004.tb00493.x · DOI · Paper page
- 10.1016/S0896-6273(03)00294-0 · DOI · Paper page
Cited by
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Autophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
The complexity of Alzheimer’s disease: an evolving puzzle
Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 309
Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients
HNRC, Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., & Masliah, E. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9152-8 · Cited by 205
“In Alzheimer’s disease (AD) and other neurodegenerative disorders, this is manifested by increased accumulation of Aβ into toxic oligomers (Barghorn et al. 2005; Deshpande et al. 2006; Glabe 2008; Shin et al. 2008; Standridge 2006; Tsigelny et al. 2008; Watson et al. 2005; White et al. 2005; Wisniewski and Konietzko 2…”
BackgroundHong, W., Wang, Z., Liu, W., O’Malley, T. T., Jin, M., Willem, M., Haass, C., Frosch, M. P., & Walsh, D. M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1846-7 · Cited by 163
Metadata
- Authors
- Watson, D., Castaño, E., Kokjohn, T. A., Kuo, Y.-M., Lyubchenko, Y., Pinsky, D., Connolly, E. S., Esh, C., Luehrs, D. C., Stine, W. B., Rowse, L. M., Emmerling, M. R., & Roher, A. E.
- Venue
- Neurological Research
- Publisher
- Informa UK Limited
- Published
- 2005-12
- Volume
- 27
- Issue
- 8
- Pages
- 869-881
- ISSN
- 0161-6412
- 1743-1328
- Cited by
- 105
- References
- 33
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physicochemical characteristics of soluble oligomeric A β and their pathologic role in Alzheimer's disease. https://app.cochat.ai/papers/10.1179/016164105x49436
- The paper
- Watson, D., Castaño, E., Kokjohn, T. A., Kuo, Y.-M., Lyubchenko, Y., Pinsky, D., Connolly, E. S., Esh, C., Luehrs, D. C., Stine, W. B., Rowse, L. M., Emmerling, M. R., & Roher, A. E. (2005). Physicochemical characteristics of soluble oligomeric A β and their pathologic role in Alzheimer's disease. Neurological Research. https://doi.org/10.1179/016164105x49436
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.